Vident Investment Advisory, LLC Immunity Bio, Inc. Transaction History

Vident Investment Advisory, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.35 - $4.78 $3,987 - $14,120	-2,954 Reduced 2.68%	107,144 $195,000
Q4 2022 Feb 14, 2023	SELL	$4.35 - $6.77 $369,876 - $575,646	-85,029 Reduced 43.58%	110,098 $558,000
Q3 2022 Nov 14, 2022	SELL	$3.65 - $6.43 $76,087 - $134,039	-20,846 Reduced 9.65%	195,127 $969,000
Q2 2022 Aug 15, 2022	BUY	$2.68 - $6.14 $38,551 - $88,323	14,385 Added 7.14%	215,973 $804,000
Q1 2022 May 16, 2022	BUY	$5.05 - $7.53 $167,215 - $249,333	33,112 Added 19.65%	201,588 $1.13 Million
Q4 2021 Feb 14, 2022	BUY	$5.67 - $10.18 $400,993 - $719,949	70,722 Added 72.35%	168,476 $1.02 Million
Q3 2021 Nov 12, 2021	SELL	$9.17 - $14.24 $64,024 - $99,423	-6,982 Reduced 6.67%	97,754 $952,000
Q2 2021 Aug 13, 2021	BUY	$13.41 - $22.4 $1.4 Million - $2.35 Million	104,736 New	104,736 $1.5 Million

213

71.2M

1.64M

1.45M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.3B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.